Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, Gallucci M, Frontini L, Piva L, Amadori D
Divisione di Oncologia Medica, Ospedale Pierantoni, Forli, Italy.
Cancer. 1995 May 15;75(10):2613-22. doi: 10.1002/1097-0142(19950515)75:10<2613::aid-cncr2820751032>3.0.co;2-1.
The individualization of prognostic factors in the various stages of cancer facilitates the planning of a therapeutic assistance program aimed at various subsets of patients. The prognostic factors for survival in patients terminally ill with cancer have been investigated in case studies that are often retrospective, monocentric and/or include a mixture of patients in advanced disease stages. The aim of this prospective multicentric study was to verify those clinical factors predictive of survival in a population of patients with terminal cancer.
This prospective and multicentric study was performed on 540 patients with solid tumors in the disseminated phase, no longer subject to specific therapy. Patients were evaluated at study entry and every 4 weeks thereafter. The analysis was performed for 23 clinical parameters.
Of 530 assessable patients with a median survival of 32 days, 15 factors were found to be statistically significant prognostic factors. By univariate analysis, 13 factors were found to be indicators of a worse survival: age older than 65 years (P = 0.05); palliative corticosteroid treatment (P < 0.001), anorexia (P < 0.001); dry mouth (P < 0.001); dysphagia (P < 0.001); hospitalization (P < 0.001); transfusion (P < 0.001); weight loss greater than or equal to 10% (P = 0.001); dyspnea (P = 0.01); pain (P = 0.006); increasing amount of pain-killer treatment (P = 0.01); increasing number of symptoms (P < 0.001); and worse clinical prediction of survival (P < 0.001). Two factors that correlated with a better survival rate were palliative progestin treatment (P = 0.03) and a higher Karnofsky performance status (P < 0.001). Multiple regression analysis revealed that only clinical prediction of survival, anorexia, dyspnea, palliative steroidal treatment, Karnofsky performance status, and hospitalization were independent predictors of survival.
The importance of certain clinical parameters as prognostic indicators for patients with terminal cancer (clinical experience, physical activity level, clinical symptoms relating to and unrelated to nutritional state) were confirmed; some others possible factors, such as treatment with corticosteroids and hospitalization, also were noted. These may be useful factors in the therapeutic, assistance decision-making process and may eliminate overtreatment and undertreatment resulting from philosophically preconceived attitudes, rather than from considering the patient's true pathologic condition.
癌症各阶段预后因素的个体化有助于制定针对不同患者亚组的治疗辅助计划。在一些往往是回顾性、单中心且/或纳入了处于疾病晚期的患者混合群体的病例研究中,已经对晚期癌症患者的生存预后因素进行了调查。这项前瞻性多中心研究的目的是验证那些可预测晚期癌症患者生存的临床因素。
这项前瞻性多中心研究对540例处于播散期、不再接受特定治疗的实体瘤患者进行。在研究开始时以及此后每4周对患者进行评估。对23项临床参数进行了分析。
在530例可评估患者中,中位生存期为32天,发现15项因素是具有统计学意义的预后因素。通过单因素分析,发现13项因素提示生存预后较差:年龄大于65岁(P = 0.05);姑息性皮质类固醇治疗(P < 0.001)、厌食(P < 0.001);口干(P < 0.001);吞咽困难(P < 0.001);住院(P < 0.001);输血(P < 0.001);体重减轻大于或等于10%(P = 0.001);呼吸困难(P = 0.01);疼痛(P = 0.006);止痛药治疗量增加(P = 0.01);症状数量增加(P < 0.001);以及生存的临床预测较差(P < 0.001)。与较高生存率相关的两项因素是姑息性孕激素治疗(P = 0.03)和较高的卡氏功能状态(P < 0.001)。多元回归分析显示,只有生存的临床预测、厌食、呼吸困难、姑息性类固醇治疗、卡氏功能状态和住院是生存的独立预测因素。
某些临床参数作为晚期癌症患者预后指标的重要性得到了证实(临床经验、身体活动水平、与营养状态相关和不相关的临床症状);还注意到了其他一些可能的因素,如皮质类固醇治疗和住院。这些可能是治疗、辅助决策过程中的有用因素,并且可以消除由于先入为主的观念而非考虑患者的真实病理状况导致的过度治疗和治疗不足。